Wuhan Hiteck Biological Pharma (300683.SZ) announced that the company participated in the tenth batch of national centralized Pharmaceutical procurement organized by the national organization.
According to the announcement by Zhitong Finance APP, Wuhan Hiteck Biological Pharma (300683.SZ) announced that the company participated in the tenth batch of national centralized Pharmaceutical procurement organized by the national organization. According to the public notice of the proposed selection results for national centralized Pharmaceutical procurement released by the joint procurement office, the company’s products, injectable hydrochloride rosiglitazone acetate and hexylmethylsugar injection, are proposed to be selected for this centralized procurement.